文献速递心境障碍焦虑、强迫与应激相关障碍

创伤后应激障碍严重程度与美国退伍军人自杀死亡风险的回顾性队列研究

Association between post-traumatic stress disorder severity and death by suicide in US military veterans: retrospective cohort study.
PubMed 文献 · Br J Psychiatry · 2022-08-23

结果显示,PCL评分高于18即症状缓解最低阈值与评估后1个月自杀死亡率翻倍相关;症状加重与长期自杀死亡率升高25%相关;症状改善者中达到症状缓解者自杀率显著低于未缓解者(HR=0.56;95%CI 0.37-0.88)。

要点

  • PCL评分>18与评估后1个月自杀死亡率翻倍相关,随时间的推移该关联减弱。
  • PTSD症状加重与长期自杀死亡率升高25%相关。
  • 症状改善者中达到症状缓解者自杀率显著低于未缓解者(HR=0.56;95%CI 0.37-0.88)。

核心结论

  • 任何高于症状缓解最低阈值(即PCL评分>18)的PTSD症状水平与评估后1个月自杀死亡率翻倍相关。
  • PTSD症状加重与长期自杀死亡率升高25%相关。
  • 症状改善的患者中,达到症状缓解者自杀率较未达到症状缓解者有显著且持续的降低(HR=0.56;95%CI 0.37-0.88)。
  • 改善PTSD可降低自杀死亡风险,但患者必须达到症状缓解才能获得这一获益。

研究设计与样本

  • 采用多变量比例风险回归模型,按PTSD症状严重度水平定义暴露组估计自杀死亡率。
  • 对多次PCL评分的患者,额外采用按PTSD症状严重度变化水平定义暴露组的模型。
  • 自杀死亡率通过VA/国防部死亡数据仓库评估。

主要发现

  • 任何高于症状缓解最低阈值(即PCL评分>18)的PTSD症状水平与评估后1个月自杀死亡率翻倍相关。
  • 该关联随时间的推移而减弱,但中度至高度症状患者的自杀率仍持续升高。
  • PTSD症状加重与长期自杀死亡率升高25%相关。
  • 症状改善患者中,达到症状缓解者较未达到症状缓解者自杀率显著且持续降低(HR=0.56;95%CI 0.37-0.88)。

关键数值与推荐

  • 症状缓解最低阈值为PCL评分>18。
  • PCL评分>18与评估后1个月自杀死亡率翻倍相关。
  • PTSD症状加重与长期自杀死亡率升高25%相关。
  • 症状改善者中症状缓解与未缓解比较:HR=0.56;95%CI 0.37-0.88。

临床怎么用

  • 对PTSD患者应同时关注诊断与症状严重度,PCL评分>18者评估后1个月自杀死亡率为最低阈值以下的2倍。
  • PTSD症状加重与长期自杀死亡率升高25%相关,需关注症状变化轨迹。
  • 症状改善者中达到症状缓解(PCL≤18)者自杀率显著低于未缓解者(HR=0.56;95%CI 0.37-0.88)。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is mixed evidence regarding the direction of a potential association between post-traumatic stress disorder (PTSD) and suicide mortality. AIMS: This is the first population-based study to account for both PTSD diagnosis and PTSD symptom severity simultaneously in the examination of suicide mortality. METHOD: Retrospective study that included all US Department of Veterans Affairs (VA) patients with a PTSD diagnosis and at least one symptom severity assessment using the PTSD Checklist (PCL) between 1 October 1999 and 31 December 2018 (n = 754 197). We performed multivariable proportional hazards regression models using exposure groups defined by level of PTSD symptom severity to estimate suicide mortality rates. For patients with multiple PCL scores, we performed additional models using exposure groups defined by level of change in PTSD symptom severity. We assessed suicide mortality using the VA/Department of Defense Mortality Data Repository. RESULTS: Any level of PTSD symptoms above the minimum threshold for symptomatic remission (i.e. PCL score >18) was associated with double the suicide mortality rate at 1 month after assessment. This relationship decreased over time but patients with moderate to high symptoms continued to have elevated suicide rates. Worsening PTSD symptoms were associated with a 25% higher long-term suicide mortality rate. Among patients with improved PTSD symptoms, those with symptomatic remission had a substantial and sustained reduction in the suicide rate compared with those without symptomatic remission (HR = 0.56; 95% CI 0.37-0.88). CONCLUSIONS: Ameliorating PTSD can reduce risk of suicide mortality, but patients must achieve symptomatic remission to attain this benefit.

来源:Br J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Forehand JA, Dufort V, Gradus JL, et al. Association between post-traumatic stress disorder severity and death by suicide in US military veterans: retrospective cohort study. Br J Psychiatry. 2022. PMID: 35997207. doi:10.1192/bjp.2022.110

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。